Skip to main content
. 2020 Sep 3;3(9):e2015437. doi: 10.1001/jamanetworkopen.2020.15437

Table 1. Frequency of Presenting Symptoms Among the BRIGHTLIGHT Cohort.

Symptom Patients, No. (%) [95% CI] (Nā€‰=ā€‰803)a
Lump or swelling 419 (52) [49-56]
Extreme tiredness 308 (38) [35-42]
Unexplained pain 281 (34) [32-38]
Night sweats 192 (24) [21-27]
Lymphadenopathy 191 (24) [21-27]
Weight loss 190 (24) [21-27]
Headaches 127 (16) [13-19]
Dizziness 126 (16) [13-18]
Rash or itching 94 (12) [10-14]
Limping or mobility problems 77 (10) [8-12]
Bruising or bleeding 73 (9) [7-11]
Other symptomsb 69 (9) [7-11]
Menstrual changes 56 (7) [5-9]
Recurrent infections 47 (6) [4-8]
Mole changes 40 (5) [4-7]
Loss of vision 27 (3) [2-5]
Fits or seizures 17 (2) [1-3]
a

Total sum exceeds 803 (100%) because patients could report multiple symptoms.

b

Other symptoms include symptoms with less than 2% frequency (see eTable 1 in the Supplement).